PMS2 and adenoma: Elevated adenoma burden has been shown in about 6% of LS patients, and multiple cumulative adenomas are particularly observed in carriers of pathogenic MSH6 and PMS2 gene variants as well as individuals with CMMRD (8, 34, 35).